Company / SG&A per Share
Mirum Pharmaceuticals, Inc. SG&A per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$5.32
FY2025
5-year range
$0.76 / $5.32
FY2021-FY2025
Trend
+22.9%
vs FY2024
Sector context
#29 of 210
Health Care
What the data says
Mirum Pharmaceuticals, Inc.'s sg&a per share of $5.32 is higher than 86% of companies in the Health Care sector (FY2025). SG&A per Share has increased for 4 consecutive years, from $0.76 in FY2021 to $5.32 in FY2025.
Based on SEC 10-K filings.
5.32 in FY2025 with a 5-year CAGR of +42.7%. Top quartile in the Health Care sector.
Increased from $3.95 to $5.32 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +40.0%
- 5-Year CAGR
- +42.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 210This company $5.32 Sector average $29.50
▼
-82.0% below sector average
Key checks
Key Insights
- Mirum Pharmaceuticals, Inc.'s sg&a per share has grown for 4 consecutive years.
- In FY2025, sg&a per share increased 22.9% year-over-year.
- Ranks #29 out of 210 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -26.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.32 | +22.9% |
| FY2024 | $4.33 | +9.6% |
| FY2023 | $3.95 | +103.9% |
| FY2022 | $1.94 | +154.1% |
| FY2021 | $0.76 | -15.2% |
| FY2020 | $0.90 | -12.2% |
| FY2019 | $1.02 | +57.3% |
| FY2018 | $0.65 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026